Press Releases
Egalet Announces OXAYDO® Receives Pharmaceutical Composition Patent Protection Through 2024
Egalet Corporation , a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,announced the issuance of a United States patent covering OXAYDO® (oxycodone HCI, USP) tablets for oral use only–CII....
Press Releases
Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System – the First Commercially Available Patient-matched Glenoid Implant
Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare,announced the launch of the Comprehensive® Vault Reconstruction System (VRS),the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss...
Press Releases
Largest Ever PACK EXPO Exceeds Highest of Expectations
On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the world’s largest and most comprehensive processing and packaging show in 2016. Show owner and producer PMMI, The Association...
Press Releases
MedImmune completes out-licensing agreement with Allergan for MEDI2070
AstraZeneca announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global rights to MEDI2070. MEDI2070 is an IL-23 monoclonal antibody currently in a Phase...
Press Releases
Largest Ever PACK EXPO Exceeds Highest of Expectations
On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the world’s largest and most comprehensive processing and packaging show in 2016.Show owner and producer PMMI, The Association for Packaging and Processing...
Press Releases
Allergan Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improve Patient-Physician Conversations About Irritable Bowel Syndrome with Diarrhea (IBS-D)
Allergan plc announced a national partnership with Amy Dixon, world champion paratriathlete and irritable bowel syndrome with diarrhea (IBS-D) patient. Through this partnership, Dixon will serve as a spokesperson to share her story with fellow IBS-D...
Press Releases
Shire launches CUVITRU™ [Immune Globulin Subcutaneous (Human), 20% Solution] in the U.S. for Primary Immunodeficiency
Shire plc announces the launch of CUVITRU , 20% Solution], the first and only Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric patients (two years of age and older) with primary immunodeficiency...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















